Report Description Report Description and Highlights

India Pharmaceutical Market Trends :

One of the primary factors driving the market is the sudden outbreak of the coronavirus disease (COVID-19), across the nation. Additionally, the extensive utilization of intelligent automation in the pharmaceutical industry to diagnose and manage diseases is creating a positive market outlook. Other than this, the industry is positively influenced by the introduction of single-window system to streamline drug development procedures and assist in fast approvals of commercially viable projects. Besides this, the increasing aging population has led to a rise in the number of individuals diagnosed with chronic illnesses, such as rheumatoid arthritis, hypertension, cancer, and diabetes. In line with this, the pharmaceutical industry has expanded exponentially across the country by developing cost-effective, new technologies and more efficient manufacturing techniques. Furthermore, extensive research and development (R&D) activities performed by the Government of India to support rapid drug discovery for better health outcomes are creating lucrative growth opportunities for key players operating in the industry. Other growth-inducing factors are expanding income levels, improving medical infrastructure, lower manufacturing costs, a highly skilled workforce, and enhanced marketing and distribution system.

Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).